- Published on
Medicine – Respiratory Complications of HIV Infection
Respiratory complications are major causes of morbidity and mortality in patients with human immunodeficiency virus (HIV) infection.
They may result from viral, bacterial, mycobacterial or fungal infections. The spectrum of respiratory disease depends on the degree of immunosuppression, CD4+ T-cell count, antiretroviral therapy (ART) status and exposure to infectious organisms.
- Viral infections: adenovirus, influenza and CMV.
- Bacterial infections: Streptococcus pneumoniae and Staphylococcus aureus.
- Mycobacterial infections: tuberculosis and Mycobacterium avium complex.
- Pneumocystis jirovecii pneumonia (PCP).
- Other fungal infections: Candida, Histoplasma and Cryptococcus.
1. Overview of Respiratory Complications
Classification of important infectious respiratory complications in HIV.
2. Viral Respiratory Infections
A. Adenovirus
Adenovirus is a non-enveloped, double-stranded DNA virus that can cause upper and lower respiratory tract infections.
Although infection is often self-limiting in immunocompetent individuals, patients with advanced HIV may develop severe or disseminated disease.
Clinical Features
- Fever.
- Sore throat.
- Cough.
- Nasal congestion.
- Dyspnoea.
- Pneumonia in severe cases.
Diagnosis
- Respiratory tract PCR testing.
- Chest radiography when pneumonia is suspected.
- Additional investigations for disseminated infection when indicated.
Treatment
Management is predominantly supportive. Severe adenovirus disease may require specialist-directed antiviral therapy, although evidence for specific treatments is limited.
B. Influenza
Influenza is caused by influenza A or B viruses. Patients with HIV, particularly those with advanced immunosuppression, may have an increased risk of severe disease.
Clinical Features
- Sudden-onset fever.
- Dry cough.
- Myalgia.
- Headache.
- Malaise.
- Sore throat.
- Dyspnoea in severe cases.
Complications
- Primary viral pneumonia.
- Secondary bacterial pneumonia.
- Respiratory failure.
- Exacerbation of underlying respiratory disease.
Secondary bacterial pneumonia may be caused by Streptococcus pneumoniae or Staphylococcus aureus.
Diagnosis and Treatment
- Respiratory nucleic acid amplification testing.
- Oseltamivir or another appropriate influenza antiviral.
- Supportive care.
- Treatment of secondary bacterial infection when present.
- Annual influenza vaccination for prevention.
C. Cytomegalovirus (CMV)
CMV is a herpesvirus that may reactivate in patients with severe immunosuppression, particularly when the CD4 count falls below approximately 50 cells/µL.
CMV may affect the lungs, retina, gastrointestinal tract and central nervous system.
Clinical Features of CMV Pneumonitis
- Fever.
- Dry cough.
- Progressive dyspnoea.
- Hypoxaemia.
- Diffuse pulmonary infiltrates.
True CMV pneumonitis is relatively uncommon in patients with HIV, even when CMV is detected in respiratory specimens.
Diagnosis
- Compatible clinical and radiological findings.
- Assessment for alternative causes of pneumonia.
- Evidence of CMV-associated pulmonary tissue disease.
CMV DNA detected in bronchoalveolar lavage fluid alone does not establish CMV pneumonitis.
Treatment
Confirmed severe CMV pneumonitis may require intravenous ganciclovir or other specialist-directed antiviral treatment.
3. Bacterial Respiratory Infections
Bacterial pneumonia can occur at any CD4 count and is an important respiratory complication of HIV infection.
A. Streptococcus pneumoniae
Streptococcus pneumoniae is a Gram-positive, encapsulated, lancet-shaped diplococcus.
It is a major cause of community-acquired bacterial pneumonia.
Clinical Features
- Acute fever.
- Productive cough.
- Purulent sputum.
- Pleuritic chest pain.
- Dyspnoea.
- Tachypnoea.
Chest Radiograph
Classically demonstrates lobar consolidation, although bronchopneumonia and other patterns may occur.
Illustration: Lobar Pneumonia
Schematic illustration of pulmonary consolidation.
View real lobar pneumonia chest radiographsComplications
- Bacteraemia.
- Empyema.
- Sepsis.
- Respiratory failure.
Diagnosis and Treatment
- Chest radiography.
- Blood cultures in selected severe cases.
- Sputum culture when indicated.
- Pneumococcal urinary antigen testing in appropriate cases.
- Antibiotics according to community-acquired pneumonia guidelines.
- Pneumococcal vaccination for prevention.
B. Staphylococcus aureus
Staphylococcus aureus is a Gram-positive coccus arranged in clusters.
It may cause severe pneumonia, particularly following influenza or in patients with additional risk factors.
Clinical Features
- High fever.
- Productive cough.
- Dyspnoea.
- Pleuritic chest pain.
- Haemoptysis in some cases.
Complications
- Necrotising pneumonia.
- Lung abscesses.
- Cavitary pulmonary lesions.
- Empyema.
- Bacteraemia and sepsis.
Methicillin-resistant Staphylococcus aureus (MRSA) should be considered when relevant risk factors are present.
Diagnosis and Treatment
- Chest radiography or CT.
- Sputum culture.
- Blood cultures in severe disease.
- Antibiotic treatment guided by susceptibility.
- Vancomycin or linezolid may be required for MRSA pneumonia.
4. Tuberculosis in HIV Infection
Tuberculosis (TB), caused by Mycobacterium tuberculosis, is a major respiratory and systemic complication of HIV infection.
TB can occur at any CD4 count.
Unlike some opportunistic infections, tuberculosis does not require profound CD4 depletion. However, its clinical and radiological presentations vary with immune status.
Clinical Features
- Persistent cough.
- Fever.
- Night sweats.
- Weight loss.
- Fatigue.
- Haemoptysis in some cases.
Important Characteristics of TB in HIV
A. Common Respiratory Presentation
Pulmonary tuberculosis is a major cause of chronic respiratory symptoms in people living with HIV.
B. Extrapulmonary Disease Is Common
HIV increases the likelihood of disseminated and extrapulmonary tuberculosis.
- Lymph nodes.
- Meninges.
- Pleura.
- Pericardium.
- Abdomen.
- Bones and joints.
C. Chest Radiographs May Be Atypical
Classical pulmonary tuberculosis in immunocompetent adults often produces upper-lobe infiltrates and cavitation.
In advanced HIV, chest imaging may instead show:
- Lower or middle-zone infiltrates.
- Hilar or mediastinal lymphadenopathy.
- Diffuse or miliary infiltrates.
- Minimal cavitation.
- Occasionally a normal chest radiograph.
Illustration: TB Radiological Patterns
Schematic comparison. Actual imaging patterns overlap and cannot independently establish the diagnosis.
View real HIV-associated tuberculosis chest radiographsD. Drug Resistance
Drug-resistant TB, including multidrug-resistant tuberculosis (MDR-TB), is an important concern in people living with HIV.
However, HIV infection does not automatically imply drug resistance. Risk depends on prior treatment, exposure, local epidemiology and other factors.
MDR-TB is defined by resistance to at least isoniazid and rifampicin.
E. Nontuberculous Mycobacterial Infections
Advanced HIV may predispose patients to infections caused by nontuberculous mycobacteria, particularly Mycobacterium avium complex (MAC).
F. TB Can Occur at Any CD4 Count
This is a key distinction between tuberculosis and several other HIV-associated opportunistic infections.
Diagnosis of Tuberculosis
- Sputum molecular testing such as Xpert MTB/RIF or Xpert Ultra.
- Sputum smear microscopy.
- Mycobacterial culture.
- Drug-susceptibility testing.
- Chest radiography.
- Site-specific testing for extrapulmonary disease.
Treatment
Drug-susceptible TB is generally treated with an initial multidrug regimen containing:
- Isoniazid.
- Rifampicin.
- Pyrazinamide.
- Ethambutol.
Treatment duration and continuation regimens depend on disease site, susceptibility and clinical response.
ART is essential, but timing and interactions between antiretroviral and antituberculous drugs require careful management.
5. Mycobacterium avium Complex (MAC)
Mycobacterium avium complex consists of nontuberculous mycobacteria capable of causing opportunistic disease in patients with advanced HIV.
Disseminated MAC most commonly occurs when the CD4 count is below approximately 50 cells/µL.
Clinical Features
- Persistent fever.
- Night sweats.
- Weight loss.
- Fatigue.
- Diarrhoea.
- Abdominal pain.
- Lymphadenopathy.
- Anaemia.
Although pulmonary MAC disease can occur, disseminated infection is the classical presentation in advanced HIV.
Diagnosis
- Mycobacterial blood cultures in suspected disseminated disease.
- Culture or molecular testing from involved tissues.
- Imaging and site-specific investigations when indicated.
Treatment
Treatment generally includes a macrolide such as azithromycin or clarithromycin combined with ethambutol.
Additional drugs may be required in selected cases. Effective ART is essential for immune recovery.
6. Pneumocystis Pneumonia (PCP)
Pneumocystis pneumonia (PCP), also called Pneumocystis jirovecii pneumonia (PJP), is caused by the fungus Pneumocystis jirovecii.
It is a major AIDS-defining opportunistic infection.
PCP most commonly occurs when the CD4 count is below 200 cells/µL, particularly in patients not receiving effective ART or appropriate prophylaxis.
Pathogenesis
Pneumocystis jirovecii infects the alveoli, causing inflammation and impaired gas exchange.
Clinical Features
PCP typically has a subacute presentation developing over days to weeks.
- Progressive dyspnoea.
- Dry, nonproductive cough.
- Fever.
- Malaise.
- Fatigue.
- Tachypnoea.
- Hypoxaemia.
Patients may have relatively few chest auscultation findings despite significant hypoxaemia.
Chest Radiograph
Chest radiography is abnormal in most established cases, with traditional teaching estimates of approximately 90%.
- Bilateral diffuse interstitial infiltrates.
- Symmetrical perihilar opacities.
- Ground-glass changes, more clearly seen on CT.
An early chest radiograph may be normal and therefore does not completely exclude PCP.
Illustration: Diffuse Pulmonary Infiltrates
Schematic illustration of bilateral diffuse pulmonary infiltrates.
View real PCP chest radiographsDiagnosis
- Pulse oximetry.
- Arterial blood gas in moderate or severe disease.
- Chest radiography or CT.
- Induced sputum or bronchoalveolar lavage.
- Pneumocystis PCR or staining.
- Serum beta-D-glucan as a supportive, nonspecific test.
Treatment
First-line treatment is high-dose co-trimoxazole (trimethoprim-sulfamethoxazole, TMP-SMX), generally for 21 days in patients with HIV.
Adjunctive Corticosteroids
Adjunctive corticosteroids are recommended for moderate-to-severe PCP, commonly defined by:
- Arterial PaO2 below 70 mmHg on room air, or
- Alveolar–arterial oxygen gradient of at least 35 mmHg.
When indicated, corticosteroids should be started early, ideally within 72 hours of beginning anti-PCP treatment.
Prophylaxis
TMP-SMX is also used for primary and secondary prophylaxis in patients meeting guideline-defined criteria, commonly involving low CD4 counts and inadequate viral suppression.
7. Other Fungal Respiratory Infections
A. Candida Species
Candida species frequently colonise the oropharynx and may be detected in respiratory specimens.
However, true Candida pneumonia is extremely rare, including in patients with HIV.
Candida isolated from sputum or bronchoalveolar lavage usually represents colonisation rather than invasive pulmonary infection.
Clinical Features of True Invasive Disease
- Fever.
- Cough.
- Dyspnoea.
- Pulmonary infiltrates.
Diagnosis and Treatment
- Histopathological evidence of tissue invasion is generally required.
- Systemic antifungal treatment is guided by species and susceptibility.
- Assessment for disseminated candidiasis is important.
B. Histoplasmosis
Histoplasmosis is caused by Histoplasma capsulatum, a dimorphic fungus.
Infection is generally acquired through inhalation of environmental fungal spores.
Patients with advanced HIV are at risk of disseminated histoplasmosis, especially in endemic regions.
Clinical Features
- Fever.
- Cough.
- Dyspnoea.
- Weight loss.
- Night sweats.
- Hepatosplenomegaly in disseminated disease.
- Lymphadenopathy.
- Pancytopenia in severe disseminated infection.
Diagnosis
- Histoplasma antigen testing in urine or serum.
- Fungal culture.
- Histopathological examination.
- Molecular testing where available.
Treatment
- Severe disseminated disease: liposomal amphotericin B followed by itraconazole.
- Milder disease: itraconazole in appropriate cases.
- ART and management of associated immunosuppression.
C. Cryptococcus neoformans
Cryptococcus neoformans is an encapsulated yeast.
Infection is usually acquired through inhalation, with possible dissemination to the central nervous system.
Clinical Features
- Cough.
- Fever.
- Dyspnoea.
- Chest discomfort.
- Pulmonary nodules or infiltrates.
- Disseminated disease in advanced immunosuppression.
Diagnosis
- Serum cryptococcal antigen testing.
- Respiratory or tissue fungal culture.
- Histopathology.
- Evaluation for CNS involvement when indicated.
Treatment
- Mild isolated pulmonary disease: fluconazole in appropriate cases.
- Severe pulmonary or disseminated disease: amphotericin B-based treatment, with flucytosine when appropriate.
- ART and immune restoration, with timing adapted to any CNS involvement.
8. Comparison of Respiratory Complications
| Condition | Typical Presentation | Important Clue |
|---|---|---|
| Adenovirus | Fever, cough, respiratory infection | May be severe in advanced immunosuppression |
| Influenza | Acute fever, myalgia, cough | Secondary bacterial pneumonia |
| CMV pneumonitis | Fever, dry cough, hypoxaemia | Advanced HIV; tissue disease must be established |
| Pneumococcal pneumonia | Acute fever, productive cough | Lobar consolidation |
| S. aureus pneumonia | Severe pneumonia, sometimes haemoptysis | Necrosis or cavitation |
| Tuberculosis | Chronic cough, fever, weight loss | Can occur at any CD4 count |
| Disseminated MAC | Fever, weight loss, diarrhoea | CD4 commonly below 50 |
| PCP | Dry cough, progressive dyspnoea | CD4 commonly below 200; hypoxaemia |
| Candida pneumonia | Rare invasive pulmonary infection | Respiratory Candida usually represents colonisation |
| Histoplasmosis | Pulmonary or disseminated disease | May mimic TB |
| Cryptococcosis | Pulmonary nodules or infiltrates | May disseminate to CNS |
9. Typical CD4 Count Associations
These are approximate clinical associations, not strict diagnostic thresholds.
10. High-Yield Examination Summary
Viral Infections
- Adenovirus: may cause severe respiratory disease.
- Influenza: acute infection with risk of secondary bacterial pneumonia.
- CMV: pneumonitis is uncommon but may occur in advanced HIV.
Bacterial Infections
- Streptococcus pneumoniae: major cause of bacterial pneumonia.
- Staphylococcus aureus: may cause necrotising or cavitating pneumonia.
Tuberculosis
- Can occur at any CD4 count.
- Extrapulmonary and disseminated disease are more common in advanced HIV.
- Chest radiographs may be atypical.
- Drug-resistant TB is an important concern.
Pneumocystis Pneumonia
- Usually occurs with CD4 below 200 cells/µL.
- Dry cough, fever, malaise and progressive dyspnoea.
- Hypoxaemia and diffuse bilateral infiltrates.
- High-dose co-trimoxazole is first-line treatment.
- Adjunctive corticosteroids for moderate-to-severe disease.
Other Fungal Infections
- Candida: respiratory isolation usually represents colonisation.
- Histoplasmosis: pulmonary or disseminated fungal infection.
- Cryptococcus: pulmonary infection with possible CNS dissemination.
Tuberculosis can occur at any CD4 count, whereas PCP is particularly associated with CD4 counts below 200 cells/µL. TB may have an atypical chest radiograph in advanced HIV, while PCP classically produces diffuse bilateral pulmonary infiltrates and significant hypoxaemia.
New or worsening breathlessness, low oxygen saturation, chest pain or respiratory distress requires urgent medical assessment.
Kembara Xtra – Medicine Revision Notes